U.S. Gov't Will Legalize Doctor's Marijuana on August 1st

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone
U.S. Gov't Will Legalize Doctor's Marijuana on August 1st 2016



The U.S. Drug Enforcement Administration will reclassify marijuana as a "Schedule Two" drug on August 1, 2016, essentially legalizing medicinal cannabis in all 50 states with a doctor's prescription, said a DEA lawyer with knowledge of the matter.

The DEA Lawyer had told the lawyer representing a DEA informant of the DEA's plan to legalize medicinal cannibis nationwide on August 1, 2016. When questioned by our reporter, the DEA lawyer felt compelled to admit the truth to him as well.

"Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states," the DEA attorney told the Observer. Federal Preemption is a legal doctrine that where the US Government regulates a particular field, State and local laws are overridden and of no effect.

He explained that "there are five DEA schedules. Nothing on Schedule One is ever legal, and that is where Cannabis is today. Schedule Two drugs are available with a prescription."

On Schedule Two, marijuana will join drugs like Percocet, Xanax, Oxycontin, Abilify and other drugs that are legal, even common, with a prescription. There are also other drugs that are not on any schedules but that are illegal on a federal level, he said. Drugs like aspirin and ibuprofen are available over-the-counter.

He opined that the 135 medicinal cannabis clinic owners in Los Angeles will no doubt oppose this move by the Federal government, because the rule change will eliminate any reason for people to visit medical marijuana clinics. "In my opinion, CVS pharmacy, Rite-Aid and Walgreens will sell Schedule Two THC products similar to what users call "edibles," but will not sell smokable weed because of the health risk smoking anything entails," said the DEA lawyer.

The Los Angeles based DEA Attorney who spoke to us, asked to remain anonymous because he was not authorized to speak to the press about the matter. He speculated that this action will be taken in the closing days of the 2016 U.S. Presidential election, so as to motivate the Democratic base to turn out and vote for Hillary Clinton, and other down ballot candidates. She will certainly not reverse this policy decision taken in the waning days of the Barack Obama administration, he said. But Donald Trump might.

"Marijuana enforcement is a big drain on DEA resources," he said was another reason for the change, noting that a majority of the American public favor the legalization of marijuana for medical use.

Libertarian candidate Gary Johnson is in favor of legalizing marijuana and in fact owns a business which pedals pot in New Mexico.

California will vote on November 7th, 2016, whether to legalize the recreational use of marijuana. Because of Federal preemption, the DEA's reclassification of cannabis as a Schedule Two drug, will have the legal effect of requiring a prescription in California--i.e., it will continue the status quo.

Since the Golden State legalized medical marijuana almost 20 years ago, Federal authorities have occasionally raided medical marijuana clinics here. They have forced major banks, like Bank of America, to close clinic bank accounts. The Feds have even seized real estate belonging to landlords who rent space to pot clinics. The Federal war on medicinal marijuana will abruptly end on August 1, 2016.

8/01 is the new 4/20!

Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; However, there is no single agreed upon definition, says Wikipedia. The use of cannabis as a medicine has not been rigorously scientifically tested, often due to production restrictions and other governmental regulations. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications, however, is insufficient for conclusions about safety or efficacy.

In California, there are "weed doctors" who will write a prescription for cannabis to anyone claiming to suffer from anxiety, which means they passout prescriptions for pot like chocolate bars at a Halloween party. As with so many other trends that started in California, expect to see medicinal marijuana sold in your town soon!

Medical cannabis can be administered using a variety of methods, including liquid tinctures, vaporizing or smoking dried buds, eating cannabis edibles, taking capsules, using lozenges, dermal patches or oral/dermal sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone.

Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands (where it is also legal recreationally), Portugal and Spain.

In the United States, federal law outlaws all cannabis use, while 25 states and the District of Columbia no longer prosecute individuals for the possession or sale of medical marijuana, as long as the individuals are in compliance with the state's medical marijuana sale regulations.

The DEA lawyer gave us his legal opinion that if you happen to live where recreational marijuana is now legal, i.e. Colorado or Washington State; after August 1, you will need a prescription, as you would need throughout the U.S.

However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.

As explained above, moving marijuana from Schedule One to Schedule Two, would have the effect of legalizing medicinal marijuana, throughout all 50 States, the District of Columbia and U.S. territories. This action may be taken by the DEA unilaterally--i.e., without specific Congressional authorization -- because Congress has previously granted the DEA rule-making authority over what drugs are on which schedules.

The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the U.S. Department of Justice, tasked with combating drug smuggling and use within the United States. Not only is the DEA the lead agency for domestic enforcement of the Controlled Substances Act, sharing concurrent jurisdiction with the Federal Bureau of Investigation (FBI) and Immigration and Customs Enforcement (ICE), it also has sole responsibility for coordinating and pursuing U.S. drug investigations abroad.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infiterra Streamlines Subscription Commerce for MSPs

Updated Category News Views 53

Revolutionizing How MSPs Navigate Subscription Commerce Just when you thought subscription commerce for IT might plateau, Infiterra's stepping up with some slick integration magic. They're rolling out tools that are about to make life a lot easier for Managed Service Providers (MSPs) and IT distributors. Yeah, the technological world spins fast, and these folks want in on...

Continue Reading
Urenco's LEU+ Boosts Future Nuclear Reactor Options

Updated Category News Views 16

Urenco's Leap Forward with LEU+ Well, look who’s shaking up the nuclear scene—Urenco USA, that’s who. They’ve just churned out their first cylinder of low-enriched uranium plus (LEU+) at the National Enrichment Facility in Eunice, New Mexico. This isn’t just any regular Tuesday of uranium talk; it marks a seismic shift for nuclear fuel options in the Western...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 0

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Milwaukee Cylinder Unveils Tech for Longevity in Tough Conditions

Updated Category News Views 54

Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...

Continue Reading
Tips to Pick the Right Primary Care Provider

Updated Category News Views 0

Deciding on Your Healthcare Anchor The quest for the perfect primary care provider isn't just routine; it's a cornerstone to your overall healthcare strategy. When Healthcare Services Expert Sheila A. Berschauer from Moses Lake Community Health lays it all out in HelloNation, she pinpoints selecting a provider as one of the mightiest decisions in your health journey. This...

Continue Reading
Silicone Fluids Market Forecast Hits $10.15B by 2031

Updated Category News Views 84

Unpacking the Prevailing Expansion The global silicone fluids market is marching on a path to significant growth, projected to hit a hefty $10.15 billion by 2031. Now, if you think that's just another number, let's break down why this matters and how the market is changing its stripes. The Rising Tide of Silicone Applications Silicone fluids are not just sliding under the...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 119

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading
Downsizing Tips for Seniors: Start Early, Plan Smart

Updated Category News Views 13

When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 53

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
ATS Energy Adds Shell Veteran to Fuel Big Ambitions

Updated Category News Views 0

ATS Energy: Charging Ahead with New Leadership There's nothing quite like the spark of new leadership to rev up the energy sector, and ATS Energy—fresh off its Earthshot Prize win—has just thrown in a turbocharged trio. Bringing in seasoned pros with stacks of industrial technology, finance, and infrastructure chops, this isn't your run-of-the-mill board shakeup. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Jones Lang LaSalle's Impressive Growth Potential

Updated Category News Views 167

Analyzing the Growth of Jones Lang LaSalle Jones Lang LaSalle (NYSE: JLL) has delivered remarkable results in the investment landscape over the past five years, showcasing an annualized return that exceeds market expectations by 5.97%. This impressive figure translates into an average annual return of 21.36%, highlighting the strength and reliability of JLL as an...

Continue Reading
Akari Therapeutics to Present at Annual Cancer Meeting

Updated Category News Views 155

Exciting Presentation by Akari Therapeutics at Upcoming Conference Akari Therapeutics, Plc (NASDAQ: AKTX), a pioneering oncology biotechnology firm specializing in antibody drug conjugates (ADCs), has recently achieved a significant milestone. Their abstract has been accepted for oral presentation at a major cancer conference, poised to take place in the near future. This...

Continue Reading
Anchin Expands Leadership with Two New Partners Joining

Updated Category News Views 181

Anchin Welcomes New Partners to Its Growing Team Anchin, a prominent accounting and advisory firm, has exciting news to share about its team's expansion. The firm is proud to announce the addition of two accomplished professionals, Ryan Babiak and Thomas Miranda, to its partnership. As a tax partner and an audit partner, respectively, they bring fresh expertise and...

Continue Reading
StarKist Partners with Kyle Busch Family for Exciting Season

Updated Category News Views 155

StarKist and the Busch Family Kick Off NASCAR 2026 As the exhilarating NASCAR season launches, StarKist Co. is excited to announce its partnership with NASCAR champion Kyle Busch, wellness advocate Samantha Busch, and young racer Brexton Busch. Building upon a successful initial year, this collaboration emphasizes the importance of healthy, ready-to-eat protein options...

Continue Reading
Highlighting Major Tech Developments: Key Releases This Month

Updated Category News Views 177

July in Review: Key Technology Announcements July saw a flurry of significant announcements in the tech world, showcasing innovations and strategies that are set to redefine various industries. This roundup offers insights into the most noteworthy developments that emerged throughout the month. Premarket Highlights Several announcements captured the industry’s...

Continue Reading